A human antibody selective for transthyretin amyloid removes cardiac amyloid through phagocytic immune cells
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A human antibody selective for transthyretin amyloid removes cardiac amyloid through phagocytic immune cells
Authors
Keywords
-
Journal
Nature Communications
Volume 12, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-25
DOI
10.1038/s41467-021-23274-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Advances in the treatment of hereditary transthyretin amyloidosis: A review
- (2019) Morie A. Gertz et al. Brain and Behavior
- Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis
- (2019) Matthias Schmidt et al. Nature Communications
- Cerebral amyloid angiopathy and Alzheimer disease — one peptide, two pathways
- (2019) Steven M. Greenberg et al. Nature Reviews Neurology
- Gantenerumab reduces amyloid-β plaques in patients with prodromal to moderate Alzheimer’s disease: a PET substudy interim analysis
- (2019) Gregory Klein et al. Alzheimers Research & Therapy
- Prevalence of Cardiac Amyloidosis in Patients Referred for Transcatheter Aortic Valve Replacement
- (2018) Paul R. Scully et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
- (2018) David Adams et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
- (2018) Merrill D. Benson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Repeat doses of antibody to serum amyloid P component clear amyloid deposits in patients with systemic amyloidosis
- (2018) Duncan B. Richards et al. Science Translational Medicine
- Structural and kinetic basis for the selectivity of aducanumab for aggregated forms of amyloid-β
- (2018) Joseph W. Arndt et al. Scientific Reports
- Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy
- (2018) Mathew S. Maurer et al. NEW ENGLAND JOURNAL OF MEDICINE
- A human-derived antibody targets misfolded SOD1 and ameliorates motor symptoms in mouse models of amyotrophic lateral sclerosis
- (2018) Marcel Maier et al. Science Translational Medicine
- Development of an aggregate-selective, human-derived α-synuclein antibody BIIB054 that ameliorates disease phenotypes in Parkinson's disease models
- (2018) Andreas Weihofen et al. NEUROBIOLOGY OF DISEASE
- Effector-attenuating Substitutions That Maintain Antibody Stability and Reduce Toxicity in Mice
- (2017) Megan Lo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Magnetic Resonance in Transthyretin Cardiac Amyloidosis
- (2017) Ana Martinez-Naharro et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy
- (2016) Youssef Bennani Smires et al. INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING
- Cardiac Amyloid Load
- (2016) Arnt V. Kristen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Genotype and Phenotype of Transthyretin Cardiac Amyloidosis
- (2016) Mathew S. Maurer et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease
- (2016) Jeff Sevigny et al. NATURE
- Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction
- (2015) Esther González-López et al. EUROPEAN HEART JOURNAL
- The Diversity of Mechanisms Influenced by Transthyretin in Neurobiology: Development, Disease and Endocrine Disruption
- (2015) B. Alshehri et al. JOURNAL OF NEUROENDOCRINOLOGY
- Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis
- (2015) Morie A. Gertz et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Therapeutic Clearance of Amyloid by Antibodies to Serum Amyloid P Component
- (2015) Duncan B. Richards et al. NEW ENGLAND JOURNAL OF MEDICINE
- Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis
- (2015) Thomas A. Treibel et al. Journal of Cardiovascular Computed Tomography
- Repurposing Diflunisal for Familial Amyloid Polyneuropathy
- (2015) John L. Berk et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Amyloid Cardiomyopathy in Hereditary Transthyretin V30M Amyloidosis - Impact of Sex and Amyloid Fibril Composition
- (2015) Sandra Arvidsson et al. PLoS One
- Left Ventricular Amyloid Deposition in Patients With Heart Failure and Preserved Ejection Fraction
- (2014) Selma F. Mohammed et al. JACC-Heart Failure
- Guideline of transthyretin-related hereditary amyloidosis for clinicians
- (2013) Yukio Ando et al. Orphanet Journal of Rare Diseases
- Nearly 200 X-Ray Crystal Structures of Transthyretin: What Do They Tell Us About This Protein and the Design of Drugs for TTR Amyloidoses?
- (2012) S. K. Palaninathan CURRENT MEDICINAL CHEMISTRY
- Alzheimer's Aβ(1-40) Amyloid Fibrils Feature Size-Dependent Mechanical Properties
- (2010) Zhiping Xu et al. BIOPHYSICAL JOURNAL
- Antibodies to human serum amyloid P component eliminate visceral amyloid deposits
- (2010) Karl Bodin et al. NATURE
- Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation inalpha2‐macroglobulinandtau: A population‐based autopsy study
- (2008) Maarit Tanskanen et al. ANNALS OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search